A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia

Condition:   Leukemia Intervention:   Other: No Intervention Sponsor:   Takeda Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials